S. Johnston (London, United Kingdom), M. Bafadhel (Oxford (Oxfordshire), United Kingdom)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Research priorities for airway diseases in "long COVID"
O. Elneima (Leicester, United Kingdom), D. Adeloye (Edinburgh , United Kingdom), L. Daines (Edinburgh , United Kingdom), K. Poinasamy (London, United Kingdom), S. Walker (London, United Kingdom), C. Brightling (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom), P. Novotny (Leicester, United Kingdom), J. Hurst (London, United Kingdom), J. Quint (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), P. Pfeffer (London, United Kingdom), T. Drake (Edinburgh , United Kingdom), I. Rudan (Edinburgh , United Kingdom), L. Heaney (Belfast, United Kingdom), A. De Soyza (Newcastle, United Kingdom), A. Sheikh (Edinburgh , United Kingdom)
|   |
Diffusion ability of the lungs in the assessment of respiratory function in patients who have undergone the new coronavirus infection (COVID-19)
E. Filatova (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), I. Leshchenko (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), S. Skornyakov (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), I. Medvinskiy (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), N. Esaulova (Ekaterinburg (Sverdlovsk Oblast), Russian Federation), A. Polozov (Ekaterinburg (Sverdlovsk Oblast), Russian Federation)
| |
The effectiveness of telemedicine methods in the follow-up of asthma in the Covid-19 pandemic process
S. Melih Simsek (Manisa, Turkey), D. Kizilirmak (Manisa, Turkey), Y. Havlucu (Manisa, Turkey)
| |
Cough monitoring during the covid-19 pandemic
J. Smith (Manchester (Greater Manchester), United Kingdom), K. Holt (Manchester (Greater Manchester), United Kingdom), R. Dockry (Manchester (Greater Manchester), United Kingdom), H. Thornton (Ennis, Ireland), F. Keane (Ennis, Ireland), K. Mcguinness (Manchester, United Kingdom)
| |
Impact of COVID-19 on COPD and Asthma admissions and the pandemic from a patient’s perspective
D. Sykes (Hull, United Kingdom), S. Faruqi (Hull, United Kingdom), L. Holdsworth (Hull, United Kingdom), M. Crooks (Hull, United Kingdom)
| |
Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
M. Turan (Izmir, Turkey), B. Arpinar Yigitbas (Istanbul, Turkey), P. Turan (Izmir, Turkey), A. Mirici (Canakkale, Turkey)
| |
Does impact of COVID-19 pandemic reduce A&E attendances, hospital inpatient stays and re-admissions with acute exacerbation of COPD?
K. Ibrahim (Bolton, United Kingdom), R. Yadavilli (Bolton, United Kingdom), M. Ibrahim (Bolton, United Kingdom), L. Thompson (Bolton, United Kingdom), D. Scott (Bolton, United Kingdom)
| |
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
J. Paluero (Värnamo, Sweden), L. Tokhi (Värnamo, Sweden), M. Roglic (Värnamo, Sweden), M. Labor (Värnamo, Sweden)
| |
COVID-19 prevalence, risk factors and outcomes in COPD
U. Semenzato (Padova, Italy), M. Bonato (Padova, Italy), E. Bazzan (Padova, Italy), M. Romagnoli (Treviso, Italy), E. Cocconcelli (Padova, Italy), M. Tinè (Padova, Italy), G. Turato (Padova, Italy), S. Baraldo (Padova, Italy), M. Cosio (Montreal, Canada), M. Saetta (Padova, Italy)
| |
Prevalence and characteristics of COPD patients admitted for COVID-19 during the first wave.
I. DOMINGUEZ ZABALETA (Madrid, Spain), Z. Ji (Madrid, Spain), W. Giron Matute (Madrid, Spain), B. Recio Moreno (Madrid, Spain), C. Castro Riera (Madrid, Spain), A. Cerezo Lajas (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. De Miguel-Diez (Madrid, Spain)
| |
Characterization of COPD admissions during the first COVID-19 outbreak
B. García Cosío Piqueras (Palma de Mallorca, Spain), H. Shafiek (Alexandria, Egypt), N. Toledo-Pons (Palma de Mallorca, Spain), A. Iglesias (Palma de Mallorca, Spain), M. Barcelo (Palma de Mallorca, Spain), C. Represas-Represas (Vigo, Spain), L. Comeche (Madrid, Spain), P. Catalán (Castellón, Spain), A. Fernández-Villar (Vigo, Spain), J. Lopez-Campos (Sevilla, Spain), J. Echave-Sustaeta (Madrid, Spain), J. Soler-Cataluña (Valencia, Spain)
| |
Effect of quarantine ?n hospital admissions for asthma/COPD exacerbations: association with air pollution
I. Sigala (Athens, Greece), T. Giannakas (Athens, Greece), V. Giannakoulis (Athens, Greece), E. Zervas (Athens, Greece), A. Brinia (Athens, Greece), N. Gianniou (Athens, Greece), E. Dima (Athens, Greece), A. Asimakos (Athens, Greece), P. Katsaounou (Athens, Greece)
| |
Evolution and prognosis of patients with Asthma or COPD hospitalized by COVID-19 infection. Diferences between them and the patients without airway pathology.
B. Urrutia Royo (Badalona, Spain), C. Martinez Rivera (Badalona, Spain), T. Zapata (Badalona, Spain), I. Garcia Olivé (Badalona, Spain), K. Portillo (Badalona, Spain), A. Marín Tapia (Badalona, Spain), J. Abad Capa (Badalona, Spain), A. Rosell Gratacós (Badalona, Spain)
| |
Healthcare seeking behaviour in a defined COPD patient population during COVID- 19 pandemic. A mixed method study.
s. rajput (Medway, United Kingdom), S. Banerjee (Medway, United Kingdom), S. Perryman (Medway, United Kingdom), R. Sarkar (Medway, United Kingdom)
| |
The risk factors in asthma patients for COVID19 infection
T. Ignatova-Danova (Pleven, Bulgaria), I. Krachunov (Pleven, Bulgaria), N. Kyuchukov (Pleven, Bulgaria), Z. Ivanova (Pleven, Bulgaria), P. Nikolova (Pleven, Bulgaria), P. Pavlov (Pleven, Bulgaria), T. Popova (Pleven, Bulgaria), Y. Ivanov (Pleven, Bulgaria)
| |
Small airway disease in symptomatic convalescents after SARS-CoV-2 infection
F. Trinkmann (Heidelberg, Germany), A. Reif (Heidelberg, Germany), M. Müller (Heidelberg, Germany), F. Trudzinski (Heidelberg, Germany), N. Kahn (Heidelberg, Germany), F. Herth (Heidelberg, Germany)
| |
Asthma management and control during COVID-19 pandemic
K. Zayen (Ariana, Tunisia), H. Snène (Ariana, Tunisia), H. Blibech (Ariana, Tunisia), W. Fenina (Ariana, Tunisia), I. El Wadhane (Ariana, Tunisia), M. Maalej (Ariana, Tunisia), A. Jebali (Ariana, Tunisia), J. Daghfous (Ariana, Tunisia), N. Mehiri (Ariana, Tunisia), N. Ben Salah (Ariana, Tunisia), B. Louzir (Ariana, Tunisia)
| |
Anxio-depressive disorders in asthma patients during the COVID-19 pandemic
K. Zayen (Ariana, Tunisia), H. Snène (Ariana, Tunisia), H. Blibech (Ariana, Tunisia), M. Maalej (Ariana, Tunisia), A. Jebali (Ariana, Tunisia), W. Fenina (Ariana, Tunisia), I. El Wadhane (Ariana, Tunisia), N. Mehiri (Ariana, Tunisia), N. Ben Salah (Ariana, Tunisia), B. Louzir (Ariana, Tunisia)
| |
Lung function indices measured by Forced Oscillation Test in post covid period - Looking beyond lung fibrosis
N. Dhadge (Pune, India), K. Rao (Pune, India), N. Vanjare (Pune, India)
| |
Reduction in hospital admissions for Acute Exacerbations of COPD during COVID-19 pandemic
M. Brennan (Galway, Ireland), A. Straszewicz (Galway, Ireland), D. Doyle (Galway, Ireland), E. Jordon (Galway, Ireland), J. Rutherford (Galway, Ireland), H. Mulryan (Galway, Ireland), N. Byrne (Galway, Ireland), A. O Regan (Galway, Ireland), M. Mcdonnell (Galway, Ireland), M. Harrison (Galway, Ireland), R. Rutherford (Galway, Ireland)
| |